LRRK2 and Parkinson disease: However, since the LRRK2 mutations have low penetrance and LBs are not always detectable in the brain of LRRK2 PD patients [76], one could argue that the processes of α-syn aggregation and neurodegeneration would be much delayed in LRRK2 rodents, never appearing during the life course.